Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway

References

• Bemis DL, Capodice JL, Desai M, et al. (2004). A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin Cancer Res 10:5282–92
   PubMed Web of Science ®Google Scholar
• Burfeind P, Chernicky CL, Rininsland F, et al. (1996). Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 93:7263–8
   PubMed Web of Science ®Google Scholar
• Chan JM, Stampfer MJ, Giovannucci E, et al. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279:563–6
   PubMed Web of Science ®Google Scholar
• Chen J, Liu L, Hou R, et al. (2011a). Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett 308:144–51
   PubMed Web of Science ®Google Scholar
• Chen J, Sun L. (2012). Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells. Horm Metab Res 44:943–8
   PubMed Web of Science ®Google Scholar
• Chen J, Zeng J, Xin M, et al. (2011b). Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 43:681–6
   PubMed Web of Science ®Google Scholar
• Coleman IM, Kiefer JA, Brown LG, et al. (2006). Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes. Neoplasia 8:862–78
   PubMedGoogle Scholar
• DiGiovanni J, Kiguchi K, Frijhoff A, et al. (2000). Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97:3455–60
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. (2010). The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21:610–18
   PubMed Web of Science ®Google Scholar
• Grzmil M, Hemmerlein B, Thelen P, et al. (2004). Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. J Pathol 202:50–9
   PubMed Web of Science ®Google Scholar
• Harris WP, Mostaghel EA, Nelson PS, Montgomery B. (2009). Androgen deprivation therapy: Progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol 6:76–85
   PubMedGoogle Scholar
• Hoimes CJ, Kelly WK. (2010). Redefining hormone resistance in prostate cancer. Ther Adv Med Oncol 2:107–23
   Google Scholar
• Jarred RA, Keikha M, Dowling C, et al. (2002). Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 11:1689–96
   PubMed Web of Science ®Google Scholar
• Kašparová M, Siatka T, Klimešová V, Dušek J. (2012). New synthetic pyridine derivate as potential elicitor in production of isoflavonoids and flavonoids in Trifolium pratense L. suspension culture. Scientific World J 2012:746412
   Google Scholar
• Key TJ, Appleby PN, Reeves GK, Roddam AW. (2010). Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530–42
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252–63
   PubMed Web of Science ®Google Scholar
• Lau KM, LaSpina M, Long J, Ho SM. (2000). Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60:3175–82
   PubMed Web of Science ®Google Scholar
• Lee MM, Gomez SL, Chang JS, et al. (2003). Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12:665–8
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Z, Kong D, et al. (2008). Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283:27707–16
   PubMed Web of Science ®Google Scholar
• Peeters PH, Lukanova A, Allen N, et al. (2007). Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14:81–90
   PubMed Web of Science ®Google Scholar
• Peng P, Gong YM, Bao PP, et al. (2012). Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 33:1056–9
   PubMedGoogle Scholar
• Pollak MN, Schernhammer ES, Hankinson SE. (2004). Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–18
   PubMed Web of Science ®Google Scholar
• Samani AA, Yakar S, LeRoith D, Brodt P. (2007). The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 28:20–47
   PubMed Web of Science ®Google Scholar
• Shimizu H, Ross RK, Bernstein L, et al. (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963–6
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. (2012). Cancer statistics, 2012. CA Cancer J Clin 62:10–29
   PubMed Web of Science ®Google Scholar
• Venkatesan B, Prabhu SD, Venkatachalam K, et al. (2010). WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal 22:809–20
   PubMed Web of Science ®Google Scholar
• Xu T, Wang NS, Fu LL, et al. (2012). Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. Mol Biol Rep 39:7743–53
   PubMed Web of Science ®Google Scholar
• Yan L, Spitznagel EL. (2009). Soy consumption and prostate cancer risk in men: A revisit of a meta-analysis. Am J Clin Nutr 89:1155–63
   PubMed Web of Science ®Google Scholar
• Ye Y, Hou R, Chen J, et al. (2012). Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation. Horm Metab Res 44:263–7
   PubMed Web of Science ®Google Scholar
• Zong WX, Li C, Hatzivassiliou G, et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162:59–69
   PubMed Web of Science ®Google Scholar